What is Johnson & Johnson's caplyta — percent change (as a percent)?

Johnson & Johnson (JNJ) reported caplyta — percent change (as a percent) of 0.0% in Q1 2026.

What does caplyta — percent change (as a percent) mean?

The percentage growth rate of sales for the CAPLYTA product line compared to a previous period.

Products & Services · Percent Change (as a percent)

CAPLYTA — Percent Change (as a percent)

This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2024

Last reportedQ1 2026Apr 22, 2026

How to read this metric

An increase indicates strong market penetration and demand for the product, while a decrease may signal market saturation, increased competition, or loss of patent exclusivity.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the CAPLYTA product line. It s...

Peer comparison

Comparable to revenue growth rates for specific pharmaceutical assets or therapeutic franchises at other large-cap biopharmaceutical companies.

Metric ID: jnj_segment_caplyta_percent_change_as_a_percent

Historical Data

9 periods

	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	0%	0%	0%	0%	0%	0%	0%	0%	0%

Range0% – 0%

Similar Metrics at Other Companies

ViatrisVTRS View metric

Gilead SciencesGILD View metric

Kimberly-ClarkKMB View metric

Eli LillyLLY View metric

BiogenBIIB View metric

Frequently Asked Questions

What is Johnson & Johnson's caplyta — percent change (as a percent)?: Johnson & Johnson (JNJ) reported caplyta — percent change (as a percent) of 0.0% in Q1 2026.
What does caplyta — percent change (as a percent) mean?: The percentage growth rate of sales for the CAPLYTA product line compared to a previous period.